Thinking of joining a study?

Register your interest

NCT06207032 | RECRUITING | Cancer


TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Sponsor:

Tempus AI

Brief Summary:

This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

Condition or disease

Cancer

Study Type : OBSERVATIONAL
Estimated Enrollment : 500 participants
Official Title : TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Actual Study Start Date : 2024-06-01
Estimated Primary Completion Date : 2029-06-01
Estimated Study Completion Date : 2029-06-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 99 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. ≥18 years of age
  • 2. Willing to participate in the research
  • 3. Able to provide informed consent
  • 4. Must be diagnosed with cancer
Exclusion Criteria
  • 1. Not willing or able to have additional blood samples collected

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Location Details

NCT06207032


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Connecticut

Eastern CT and Hematology and Oncology Associates

Norwich, Connecticut, United States, 06360

RECRUITING

United States, Illinois

Hope and Healing Cancer Services

Hinsdale, Illinois, United States, 60521

RECRUITING

United States, New Jersey

New Jersey Cancer Center

Belleville, New Jersey, United States, 07109

RECRUITING

United States, New York

Cayuga Medical Center

Ithaca, New York, United States, 14850

Loading...